BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12372711)

  • 1. Cervical cancer research focuses on the HPV E7 gene.
    Senior K
    Lancet Oncol; 2002 Oct; 3(10):585. PubMed ID: 12372711
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papillomavirus and cervical carcinogenesis.
    Stanley MA
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):663-76. PubMed ID: 11563866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia.
    Brooks LA; Sullivan A; O'Nions J; Bell A; Dunne B; Tidy JA; Evans DJ; Osin P; Vousden KH; Gusterson B; Farrell PJ; Storey A; Gasco M; Sakai T; Crook T
    Br J Cancer; 2002 Jan; 86(2):263-8. PubMed ID: 11870517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].
    Kariya M; Fujii S
    Uirusu; 2002 Dec; 52(2):287-93. PubMed ID: 12685321
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncogenic activities of human papillomaviruses.
    McLaughlin-Drubin ME; Münger K
    Virus Res; 2009 Aug; 143(2):195-208. PubMed ID: 19540281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.
    Cooper K; McGee JO
    Mol Pathol; 1997 Feb; 50(1):1-3. PubMed ID: 9208805
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of viral infection with human papillomavirus-HPV in carcinogenesis of the uterine cervix].
    Kwaśniewska A
    Postepy Hig Med Dosw; 1997; 51(5):547-65. PubMed ID: 9489454
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus in carcinogenesis of cervical cancer.
    de Silva NR; Mendis L; Perera N
    Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.
    Fernando GJ; Murray B; Zhou J; Frazer IH
    Clin Exp Immunol; 1999 Mar; 115(3):397-403. PubMed ID: 10193409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomaviruses and cervical cancer.
    McCance DJ
    J Med Microbiol; 1998 May; 47(5):371-3. PubMed ID: 9879936
    [No Abstract]   [Full Text] [Related]  

  • 13. [Strong connection between papillomavirus and cervix cancer. More precise cytology is needed, cancer transformation may occur rapidly].
    Ylitalo N; Pontén J
    Lakartidningen; 1998 Apr; 95(15):1632-6. PubMed ID: 9599461
    [No Abstract]   [Full Text] [Related]  

  • 14. Cervical cancer, HPV 16 E6, variant genotypes, and serology.
    Nindl I; Rindfleisch K; Teller K; Schneider A; Dürst M
    Lancet; 1999 Jan; 353(9147):152. PubMed ID: 10023929
    [No Abstract]   [Full Text] [Related]  

  • 15. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
    von Knebel Doeberitz M
    Eur J Cancer; 2002 Nov; 38(17):2229-42. PubMed ID: 12441259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human papillomaviruses, cell cycle and cervical cancer].
    Mougin C; Humbey O; Gay C; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):13-20. PubMed ID: 10675829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.
    Kämmer C; Tommasino M; Syrjänen S; Delius H; Hebling U; Warthorst U; Pfister H; Zehbe I
    Br J Cancer; 2002 Jan; 86(2):269-73. PubMed ID: 11870518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.
    Watts KJ; Thompson CH; Cossart YE; Rose BR
    J Clin Microbiol; 2001 May; 39(5):2009-14. PubMed ID: 11326037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
    Riethdorf S; Riethdorf L; Richter N; Löning T
    Pathobiology; 1998; 66(6):260-7. PubMed ID: 9769472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.